Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme

NCT05589961 is registered in ClinicalTrials.gov with The Second Hospital of Hebei Medical University as lead sponsor.

NCT NCT05589961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
Lead sponsor
The Second Hospital of Hebei Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2022
Completion date
July 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme